MeasurableQuantitativeAnnotation  

PubMed:31986264 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
E1 1211-1214 entity denotes men
N1 1216-1218 num denotes 30
N2 1220-1222 num denotes 73
U1 1222-1223 unit denotes %
E1 1252-1271 entity denotes underlying diseases
N1 1273-1275 num denotes 13
N2 1277-1279 num denotes 32
U1 1279-1280 unit denotes %
E2 1294-1302 entity denotes diabetes
N3 1304-1309 num denotes eight
N4 1311-1313 num denotes 20
U2 1313-1314 unit denotes %
E3 1318-1330 entity denotes hypertension
N5 1332-1335 num denotes six
N6 1337-1339 num denotes 15
U3 1339-1340 unit denotes %
E4 1348-1370 entity denotes cardiovascular disease
N7 1372-1375 num denotes six
N8 1377-1379 num denotes 15
U4 1379-1380 unit denotes %
E1 1384-1394 entity denotes Median age
N1 1399-1403 num denotes 49·0
U1 1404-1409 unit denotes years
E1 1565-1570 entity denotes fever
N1 1572-1574 num denotes 40
N2 1576-1578 num denotes 98
U1 1578-1579 unit denotes %
E2 1598-1603 entity denotes cough
N3 1605-1607 num denotes 31
N4 1609-1611 num denotes 76
U2 1611-1612 unit denotes %
E3 1620-1638 entity denotes myalgia or fatigue
N5 1640-1642 num denotes 18
N6 1644-1646 num denotes 44
U3 1646-1647 unit denotes %
E1 1677-1694 entity denotes sputum production
N1 1696-1698 num denotes 11
N2 1700-1702 num denotes 28
U1 1702-1703 unit denotes %
E2 1713-1721 entity denotes headache
N3 1723-1728 num denotes three
N4 1730-1731 num denotes 8
U2 1731-1732 unit denotes %
E3 1742-1753 entity denotes haemoptysis
N5 1755-1758 num denotes two
N6 1760-1761 num denotes 5
U3 1761-1762 unit denotes %
E4 1776-1785 entity denotes diarrhoea
N7 1787-1790 num denotes one
N8 1792-1793 num denotes 3
U4 1793-1794 unit denotes %
E1 1804-1812 entity denotes Dyspnoea
N1 1826-1828 num denotes 22
N2 1830-1832 num denotes 55
U1 1832-1833 unit denotes %
E2 1851-1893 entity denotes median time from illness onset to dyspnoea
N3 1894-1897 num denotes 8·0
U2 1898-1902 unit denotes days
N1 1920-1922 num denotes 26
N2 1924-1926 num denotes 63
U1 1926-1927 unit denotes %
E1 1948-1959 entity denotes lymphopenia
E1 2050-2085 entity denotes acute respiratory distress syndrome
N1 2087-2089 num denotes 12
N2 2091-2093 num denotes 29
U1 2093-2094 unit denotes %
E2 2098-2106 entity denotes RNAaemia
N3 2108-2111 num denotes six
N4 2113-2115 num denotes 15
U2 2115-2116 unit denotes %
E3 2120-2140 entity denotes acute cardiac injury
N5 2142-2146 num denotes five
N6 2148-2150 num denotes 12
U3 2150-2151 unit denotes %
E4 2158-2177 entity denotes secondary infection
N7 2179-2183 num denotes four
N8 2185-2187 num denotes 10
U4 2187-2188 unit denotes %
N3 2192-2194 num denotes 13
N1 2196-2198 num denotes 32
U1 2198-2199 unit denotes %
E1 2201-2209 entity denotes patients
N4 2238-2241 num denotes six
N2 2243-2245 num denotes 15
U2 2245-2246 unit denotes %
E2 2248-2252 entity denotes died
R1 N1 U1 associateOf 32,%
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R1 E1 N1 associateWith patients,32
R10 E4 N7 associateWith secondary infection,four
R10 E4 N7 associateWith secondary infection,four
R10 E4 N7 associateWith secondary infection,four
R11 E4 N8 associateWith secondary infection,10
R11 E4 N8 associateWith secondary infection,10
R11 E4 N8 associateWith secondary infection,10
R12 N8 U4 associateOf 10,%
R12 N8 U4 associateOf 10,%
R12 N8 U4 associateOf 10,%
R2 E1 N1 associateWith patients,32
R2 E1 N2 associateWith patients,15
R2 E1 N2 associateWith patients,15
R2 N1 U1 associateOf 32,%
R2 E1 N2 associateWith patients,15
R2 E1 N2 associateWith patients,15
R2 E1 N2 associateWith patients,15
R2 E1 N2 associateWith patients,15
R2 E1 N2 associateWith patients,15
R3 N2 U2 associateOf 15,%
R3 N2 U1 associateOf 15,%
R3 N2 U1 associateOf 15,%
R3 N2 U1 associateOf 15,%
R3 N2 U1 associateOf 15,%
R3 N2 U1 associateOf 15,%
R3 N2 U1 associateOf 15,%
R3 N2 U1 associateOf 15,%
R4 E2 N2 associateWith died,15
R4 E2 N3 associateWith died,13
R4 E2 N3 associateWith died,13
R4 E2 N3 associateWith died,13
R4 E2 N3 associateWith died,13
R4 E2 N3 associateWith died,13
R5 E1 N3 associateWith patients,13
R5 E2 N4 associateWith died,six
R5 E2 N4 associateWith died,six
R5 E2 N4 associateWith died,six
R5 N3 U2 associateOf 13,%
R5 E2 N4 associateWith died,six
R6 E2 N4 associateWith died,six
R6 N4 U2 associateOf six,%
R6 N4 U2 associateOf six,%
R6 N4 U2 associateOf six,%
R6 N4 U2 associateOf six,%
R7 E3 N5 associateWith acute cardiac injury,five
R7 E3 N5 associateWith acute cardiac injury,five
R7 E3 N5 associateWith acute cardiac injury,five
R7 E3 N5 associateWith acute cardiac injury,five
R8 E3 N6 associateWith acute cardiac injury,12
R8 E3 N6 associateWith acute cardiac injury,12
R8 E3 N6 associateWith acute cardiac injury,12
R8 E3 N6 associateWith acute cardiac injury,12
R9 N6 U3 associateOf 12,%
R9 N6 U3 associateOf 12,%
R9 N6 U3 associateOf 12,%
R9 N6 U3 associateOf 12,%